AI-Enhanced Cryopreservation: Automated Biotech Solution

Current cryopreservation methods rely on manual permeation of biological materials, resulting in variability, low efficiency, and high risk of contamination. The original patent addressed this issue with a device for automated permeation, but lacked integration with advanced technologies. The present invention overcomes these limitations by combining the patented device with AI, IoT, blockchain, and novel materials to create a more powerful, efficient, and secure system.

The integration of AI, IoT, blockchain, and novel materials with the patented device for automated permeation of biological materials constitutes a novel and non-obvious combination that revolutionizes the cryopreservation process. The inventive step lies in the synergistic combination of these distinct technologies, resulting in a more efficient, secure, and accurate system.

Alternative embodiments may include integrating the device with other advanced technologies, such as computer vision or robotics, to further enhance the permeation process. Variations may include adapting the system for use in different industries, such as pharmaceuticals or biotechnology, or developing miniaturized versions for point-of-care applications.

The invention has significant commercial potential in the cryopreservation industry, with applications in cell therapy, regenerative medicine, and biobanking. The market for cryopreservation solutions is expected to grow significantly, driven by increasing demand for efficient and secure methods for preserving biological materials.